Chromosome 9 open reading frame 72 (C9orf72) is a protein with unknown function and a high level of expression in the brain and spinal cord. Th e discovery of expanded heptanucleotide repeat mutations as the most common genetic cause of familial and sporadic frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) [1, 2] provided further evidence for a phenotypic spectrum with overlapping genetic [3] [4] [5] , pathological [6, 7] , and clinical [8, 9] features. C9orf72 mutant FTD and ALS (C9FTD/ALS) cases reveal a characteristic neuro pathological signature with abundant p62-positive inclusions in the hippocampus and cerebellum [6,7] and a unique pattern of ubiquilin pathology [10] . C9orf72 repeat expansion mutation in large cohorts of patients with AD has been either absent [11] or identifi ed exceed ingly rarely [12] .
Chromosome 9 open reading frame 72 (C9orf72) is a protein with unknown function and a high level of expression in the brain and spinal cord. Th e discovery of expanded heptanucleotide repeat mutations as the most common genetic cause of familial and sporadic frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) [1, 2] provided further evidence for a phenotypic spectrum with overlapping genetic [3] [4] [5] , pathological [6, 7] , and clinical [8, 9] features. C9orf72 mutant FTD and ALS (C9FTD/ALS) cases reveal a characteristic neuro pathological signature with abundant p62-positive inclusions in the hippocampus and cerebellum [6, 7] and a unique pattern of ubiquilin pathology [10] . C9orf72 repeat expansion mutation in large cohorts of patients with AD has been either absent [11] or identifi ed exceed ingly rarely [12] .
In the previous issue of Alzheimer's Research & Th erapy, Satoh and colleagues [13] present an analysis of C9orf72 expression and its relation to ubiquitin, p62, and ubiquilin-1, ubiquilin-2 immuno reactivity in control, Alzheimer's disease (AD), sporadic ALS, Parkinson's disease, and multiple system atrophy brains. Early studies have consistently shown that C9orf72 is negative in intracellular inclusions including tau-positive structures except for Pick bodies (for references, see [13] ). In contrast to these previous studies, Satoh and colleagues report C9orf72 in a subset of dystrophic neurites in AD. Another major fi nding is the demonstration of C9orf72 and ubiquilin-1 positivity in a cluster of dystrophic neurites in senile plaques in AD brains by using antibodies discriminating ubiquilin-1 from ubiquilin-2; these results warrant further studies into the role of ubiquilin in neurodegeneration. Th e thorough analysis of two diff er ent anti-C9orf72 antibodies for the pattern of immuno reactivity, specifi city, cross-reactivities is an important aspect of the study. Th e results suggest that the testing of further antibodies available on the market and the genera tion of novel highly specifi c anti-C9orf72 anti bodies are necessary to facilitate research into neurodegenerative diseases, in particular C9FTD/ALS. Unfortu nately, C9orf72 mutation status has not been analyzed in the included cases either; Satoh and colleagues assume that cases are likely to be negative in view of the low prevalence of C9orf72 mutation in ALS and FTD in Japanese patients [14] in comparison with Caucasian patients [15] . Pathological proteins incorporated into charac teristic inclu sions in neurodegenerative diseases are rather detergent-insoluble; the analysis of this key feature is still awaited. Th e case numbers are low in this study. Th erefore, as the authors themselves have suggested, further studies are needed to test the presented fi ndings in larger cohorts and by more detailed analysis. Th is paper provides a nidus around which the presented observations can be more robustly studied and clarifi ed.
Abbreviations AD, Alzheimer's disease; ALS, amyotrophic lateral sclerosis; C9FTD/ALS, frontotemporal dementia or amyotrophic lateral sclerosis (or both) linked to chromosome 9; C9orf72, chromosome 9 open reading frame 72; FTD, frontotemporal dementia.
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Abstract
Mutation in chromosome 9 open reading frame 72 (C9orf72) is a major genetic cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), referred to as C9FTD/ALS. The function of the protein is currently unknown, and the pathomechanism of C9FTD/ALS remains to be elucidated. The study by Satoh and colleagues in the previous issue of Alzheimer' s Research & Therapy presents important new fi ndings on C9orf72 protein expression in neurodegenerative disorders along with characterization of C9orf72 antibodies.
